Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tg Therapeutics (TGTX) Treasury Shares: 2016-2024

Historic Treasury Shares for Tg Therapeutics (TGTX) over the last 9 years, with Dec 2024 value amounting to $9.0 million.

  • Tg Therapeutics' Treasury Shares rose 4106.21% to $100.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $100.2 million, marking a year-over-year increase of 4106.21%. This contributed to the annual value of $9.0 million for FY2024, which is 3743.59% up from last year.
  • Per Tg Therapeutics' latest filing, its Treasury Shares stood at $9.0 million for FY2024, which was up 3,743.59% from $234,000 recorded in FY2023.
  • Tg Therapeutics' Treasury Shares' 5-year high stood at $12.0 million during FY2021, with a 5-year trough of $367,903 in FY2024.
  • For the 3-year period, Tg Therapeutics' Treasury Shares averaged around $6.2 million, with its median value being $8.7 million (2022).
  • Data for Tg Therapeutics' Treasury Shares shows a peak YoY surged of 3,743.59% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Tg Therapeutics' Treasury Shares stood at $234,000 in 2020, then remained steady at $234,000 in 2021, then remained steady at $234,000 in 2022, then remained steady at $234,000 in 2023, then skyrocketed by 3,743.59% to $9.0 million in 2024.